Ashraf Mikhail

2.3k total citations
25 papers, 746 citations indexed

About

Ashraf Mikhail is a scholar working on Hematology, Genetics and Nephrology. According to data from OpenAlex, Ashraf Mikhail has authored 25 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 9 papers in Genetics and 6 papers in Nephrology. Recurrent topics in Ashraf Mikhail's work include Erythropoietin and Anemia Treatment (14 papers), Hemoglobinopathies and Related Disorders (9 papers) and Iron Metabolism and Disorders (8 papers). Ashraf Mikhail is often cited by papers focused on Erythropoietin and Anemia Treatment (14 papers), Hemoglobinopathies and Related Disorders (9 papers) and Iron Metabolism and Disorders (8 papers). Ashraf Mikhail collaborates with scholars based in United Kingdom, Romania and France. Ashraf Mikhail's co-authors include D.M. Kemeny, Angela C. Cooper, Rajesh Shrivastava, Chris Brown, Iain C. Macdougall, Simon D. Roger, Sunil Bhandari, Jonathan Evans, Adrian Covic and David Goldsmith and has published in prestigious journals such as Journal of the American Society of Nephrology, American Journal of Kidney Diseases and Critical Care.

In The Last Decade

Ashraf Mikhail

24 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashraf Mikhail United Kingdom 13 444 220 215 106 66 25 746
Iain C. Macdougall United Kingdom 18 862 1.9× 302 1.4× 331 1.5× 146 1.4× 14 0.2× 32 1.1k
Stephanie Stringer United Kingdom 13 194 0.4× 208 0.9× 64 0.3× 43 0.4× 12 0.2× 21 574
P. Grützmacher Germany 14 253 0.6× 179 0.8× 83 0.4× 49 0.5× 21 0.3× 48 674
Prajwal Dhakal United States 14 167 0.4× 56 0.3× 55 0.3× 109 1.0× 77 1.2× 76 565
Jocelyn S. Garland Canada 16 89 0.2× 372 1.7× 71 0.3× 73 0.7× 52 0.8× 30 812
Kazunori Murata United States 15 190 0.4× 152 0.7× 48 0.2× 178 1.7× 238 3.6× 31 828
Giovanni Luca Tiscia Italy 18 379 0.9× 27 0.1× 176 0.8× 150 1.4× 15 0.2× 58 908
Angela C. Cooper United Kingdom 8 384 0.9× 209 0.9× 176 0.8× 66 0.6× 13 0.2× 8 711
Christophe Mariat France 20 180 0.4× 263 1.2× 51 0.2× 421 4.0× 267 4.0× 56 1.1k
Mark Jesky United Kingdom 16 76 0.2× 221 1.0× 37 0.2× 49 0.5× 33 0.5× 23 603

Countries citing papers authored by Ashraf Mikhail

Since Specialization
Citations

This map shows the geographic impact of Ashraf Mikhail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashraf Mikhail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashraf Mikhail more than expected).

Fields of papers citing papers by Ashraf Mikhail

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashraf Mikhail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashraf Mikhail. The network helps show where Ashraf Mikhail may publish in the future.

Co-authorship network of co-authors of Ashraf Mikhail

This figure shows the co-authorship network connecting the top 25 collaborators of Ashraf Mikhail. A scholar is included among the top collaborators of Ashraf Mikhail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashraf Mikhail. Ashraf Mikhail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhandari, Sunil, et al.. (2025). UK kidney association clinical practice guideline: update of anaemia of chronic kidney disease. BMC Nephrology. 26(1). 193–193. 2 indexed citations
3.
Kalra, Philip A., Sunil Bhandari, Rachel Davison, et al.. (2020). NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic kidney disease. BMC Nephrology. 21(1). 539–539. 10 indexed citations
4.
Mikhail, Ashraf, Staffan Schön, Sylvia Simon, et al.. (2019). A prospective observational study of iron isomaltoside in haemodialysis patients with chronic kidney disease treated for iron deficiency (DINO). BMC Nephrology. 20(1). 13–13. 6 indexed citations
5.
Mikhail, Ashraf, et al.. (2017). Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease. BMC Nephrology. 18(1). 345–345. 166 indexed citations
6.
Ratcliffe, Laura E., Wayne Thomas, Jessica Glen, et al.. (2016). Diagnosis and Management of Iron Deficiency in CKD: A Summary of the NICE Guideline Recommendations and Their Rationale. American Journal of Kidney Diseases. 67(4). 548–558. 81 indexed citations
7.
Mikhail, Ashraf, et al.. (2015). FP715MEASURING WHAT MATTERS IN KIDNEY DISEASE: THE INFLUENCE OF TREATMENT MODALITY ON QUALITY OF LIFE. Nephrology Dialysis Transplantation. 30(suppl_3). iii315–iii315. 1 indexed citations
9.
Mikhail, Ashraf, et al.. (2012). Epoetin Biosimilars in Europe: Five Years On. Advances in Therapy. 30(1). 28–40. 35 indexed citations
10.
Mikhail, Ashraf, Rajesh Shrivastava, & Donald Richardson. (2011). Renal Association Clinical Practice Guideline on Anaemia of Chronic Kidney Disease. Nephron Clinical Practice. 118(s1). c101–c124. 25 indexed citations
11.
Macdougall, Iain C., Andrzej Więcek, Beatriz Tucker, et al.. (2011). Dose-finding Study of Peginesatide for Anemia Correction in Chronic Kidney Disease Patients. Clinical Journal of the American Society of Nephrology. 6(11). 2579–2586. 18 indexed citations
12.
Shrivastava, Rajesh, et al.. (2009). An unusual cause of hypertension and renal failure: a case series of a family with Alagille syndrome. Nephrology Dialysis Transplantation. 25(5). 1501–1506. 11 indexed citations
13.
Mikhail, Ashraf, Adrian Covic, & David Goldsmith. (2008). Stimulating Erythropoiesis: Future Perspectives. Kidney & Blood Pressure Research. 31(4). 234–246. 14 indexed citations
14.
Mikhail, Ashraf. (2007). Biosimilars in Clinical Practice. Kidney & Blood Pressure Research. 30(Suppl. 1). 18–22. 1 indexed citations
15.
Roger, Simon D. & Ashraf Mikhail. (2007). Biosimilars: opportunity or cause for concern?. PubMed. 10(3). 405–10. 43 indexed citations
16.
Afzali, Behdad, et al.. (2006). Anemia After Renal Transplantation. American Journal of Kidney Diseases. 48(4). 519–536. 61 indexed citations
17.
Więcek, Andrzej & Ashraf Mikhail. (2006). European regulatory guidelines for biosimilars. Nephrology Dialysis Transplantation. 21(suppl_5). v17–v20. 25 indexed citations
18.
Campise, Mariarosaria, Ashraf Mikhail, Thomas Quaschning, Jon J. Snyder, & Alan Collins. (2005). Impact of pre-transplant anaemia correction and erythropoietin resistance on long-term graft survival. Nephrology Dialysis Transplantation. 20(suppl_8). viii8–viii12. 7 indexed citations
19.
Cooper, Angela C., et al.. (2004). Pentoxifylline Improves Hemoglobin Levels in Patients with Erythropoietin-resistant Anemia in Renal Failure. Journal of the American Society of Nephrology. 15(7). 1877–1882. 69 indexed citations
20.
Cooper, Angela C., et al.. (2003). Increased Expression of Erythropoiesis Inhibiting Cytokines (IFN-γ, TNF-α, IL-10, and IL-13) by T Cells in Patients Exhibiting a Poor Response to Erythropoietin Therapy. Journal of the American Society of Nephrology. 14(7). 1776–1784. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026